about
Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register studySeason of treatment initiation with antidepressants and suicidal behavior: A population-based cohort study in SwedenData management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.Is it possible to measure prescribing quality using only prescription data?Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy.Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs.The danish model for improvement of diabetes care in general practice: impact of automated collection and feedback of patient data.Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study.Mailed prescriber feedback in addition to a clinical guideline has no impact: a randomised, controlled trial.Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins.General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic studyPromotional methods used by representatives of drug companies: a prospective survey in general practice.Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study.Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control studyUse of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data.Hyponatremia in elderly patients treated with desmopressin for nocturia: a review of a case series.Diabetes and Breast Cancer Subtypes.Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.The Nordic countries as a cohort for pharmacoepidemiological research.Trends in the lifetime risk of COPD exacerbation requiring hospitalisation.The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.Initiating therapy with antidepressants after discontinuation of hormone therapy.Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines-A pragmatic open-label cluster-randomized controlled trial in primary care.Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.Phrenic pacing compared with mechanical ventilation.Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: a pharmacoepidemiological projection approach.Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.The impact of population ageing on future Danish drug expenditure.Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database.Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder--A nationwide cohort study.Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study.Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study.Impact of pharmaceutical representative visits on GPs' drug preferences.
P50
Q28544265-D3743343-046F-44CB-BBCC-26008560037EQ28949630-646FB0BB-76C4-4590-81D4-89B280ACBD02Q30980437-6CC5DA35-023D-47E5-9908-4545BE3629BAQ31036512-26D820F8-BCFA-4095-9FB3-DD4009B2C863Q33499803-3FF33539-2E74-48F8-B809-E3B56B49B034Q33505065-415C194D-95EF-4B9C-8641-5B7615423F99Q34377988-93BFEEFC-99F9-4A4B-AC68-66A5D99673EDQ34816583-49CC841C-93E9-4F1E-9A65-9D842E88D7A3Q35115989-323CEBA1-9418-41BC-8339-D1B0BA7C81D8Q35751419-9796575F-C1F4-4BDE-92FB-66B618F4B1AAQ35827238-B4D788AD-F1C6-43F7-BFDA-02D2D3DA307DQ35945612-4C6628AF-2A88-48F4-91A6-868DD562845FQ36047920-B4EAF651-E3E9-421A-98B4-224FDDA1BE68Q36047958-5592E0E6-2583-4922-8AC3-F3E8E88D3AC2Q36088013-A7BED198-E516-4AC0-91BB-197BF4A79B0AQ36093943-76217E36-A551-4866-B480-157B2419988FQ36116987-224718FD-D00C-43BF-B447-47858C939A89Q36246468-FCAF6A18-5E02-48DB-AE69-CB1DED08127AQ36793008-62EDD58B-B2C0-46DB-B9D7-D86B87C5BDBCQ37175807-F716323C-F804-40D3-A03B-E8F10E3C4827Q37644540-D5BE9F9D-7B35-4E20-B5E1-8129E8E5D34EQ38083544-E00D3A7E-DF50-4030-A1EF-582C9346DD3EQ38105056-FBB0D617-2A63-4689-BF47-B6B4EEF6B5B1Q38407850-547EC930-7DC4-4070-AA3F-545A301B78B6Q38430699-B55E4A82-654E-4C5E-868D-5813D3B1A0EDQ38629270-84287237-0C8D-4736-9BFF-13514B0CD7D5Q38749608-3C9A7B92-7235-4ABE-9122-A7A8EDB9DDF9Q38786734-9BB80A3B-3F0D-43C5-B044-65F224BE8078Q38786734-B6CC4F4A-F175-45A9-B732-7790AF45732CQ38972335-CCFCD895-1940-4981-81C6-15405CD804F3Q39300348-8F8782EC-B005-4E5F-B907-A98115847B4EQ39805925-B74ABA44-9CBE-4532-B4A1-89A0E2C4B604Q39826763-A95569E3-FA84-4EA2-A29D-747BA4A8F477Q40002064-4887044B-A136-4904-9AE0-72B59E41EC47Q40208462-42BF7018-C2B2-41DF-8639-C422FD741941Q40359657-9650866E-ADA7-42A4-BFA5-B0FCF08387CEQ40567025-E6138557-E4DC-42AF-BBB4-96396E7AF2DDQ41753488-4E6CE5C0-AEA0-4E18-B5C6-CB0C5BFEA37FQ43490348-B5FF6D3E-0AC9-436D-A265-921565014A76Q43585375-3B3C7DBB-A15D-42A0-9600-E9E773ABB7EC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Morten Andersen
@ast
Morten Andersen
@en
Morten Andersen
@es
Morten Andersen
@nl
Morten Andersen
@sl
Мортен Андерсен
@ru
type
label
Morten Andersen
@ast
Morten Andersen
@en
Morten Andersen
@es
Morten Andersen
@nl
Morten Andersen
@sl
Мортен Андерсен
@ru
prefLabel
Morten Andersen
@ast
Morten Andersen
@en
Morten Andersen
@es
Morten Andersen
@nl
Morten Andersen
@sl
Мортен Андерсен
@ru
P1053
H-3555-2011
P106
P21
P31
P3829
P496
0000-0001-7029-2860